InMode saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 74 to 81.
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating of above 80 as they launch their biggest climbs.
Hone Your Stock-Picking Skills By Focusing On These Factors
InMode is not currently near a potential buy zone. See if the stock goes on to form a promising consolidation that could launch a new move.
InMode reported negative growth for both sales and earnings last quarter.
The company holds the No. 9 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, Masimo and iRadimed are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
